MedPath

Study to compare topical methotrexate and calcipotriol in psoriasis

Phase 4
Conditions
Health Condition 1: L400- Psoriasis vulgaris
Registration Number
CTRI/2024/01/061431
Lead Sponsor
Eras Lucknow Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Psoriasis vulgaris patients with less than 10% of body surface area involvement attending dermatology OPD at Eras Lucknow Medical College and Hospital

Exclusion Criteria

1. Patients of psoriasis on topical, systemic, intralesional therapy or phototherapy for atleast 6 months prior to study

2. Patients having hypersensitivity to methotrexate or calcipotriol

3. Pregnant and lactating females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath